Lucentis (Microvascular Complications of Diabetes)：市場予測と分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 8
1.2 List of Figures 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 10
3 Disease Overview 12
3.1 Etiology and Pathophysiology 14
3.1.1 Diabetic Nephropathy 14
3.1.2 Diabetic Retinopathy 16
3.1.3 Diabetic Neuropathy 17
3.2 Prognosis 18
3.3 Quality of Life 19
3.4 Symptoms 20
4 Disease Management 21
4.1 Treatment Overview 21
4.1.1 Diagnosis and Referrals 21
4.1.2 Screening 23
4.1.3 Treatment Guidelines 24
5 Competitive Assessment 32
5.1 Overview 32
5.2 Strategic Competitor Assessment 33
6 Lucentis (ranibizumab) 37
6.1 Overview 37
6.2 Efficacy 39
6.3 Safety 40
6.4 SWOT Analysis 41
6.5 Forecast 41
7 Appendix 43
7.1 Bibliography 43
7.2 Abbreviations 48
7.3 Methodology 51
7.4 Forecasting Methodology 51
7.4.1 Diagnosed Patients 51
7.4.2 Percent Drug-Treated Patients 52
7.4.3 General Pricing Assumptions 52
7.4.4 Individual Drug Assumptions 53
7.4.5 Generic Erosion 53
7.5 Physicians and Specialists Included in this Study 54
7.6 About the Authors 56
7.6.1 Analyst II – CVMD 56
7.6.2 Therapy Director – CVMD and Infectious Disease 56
7.6.3 Global Head of Healthcare 57
7.7 About GlobalData 58
7.8 Disclaimer 58